Home Newsletters Human Immunology News Biomarkers Related to Immune Checkpoint Inhibitors Therapy

Biomarkers Related to Immune Checkpoint Inhibitors Therapy

0
The development of biomarkers is important for monitoring the effect of treatment, assessing the patient’s response to immune checkpoint inhibitors, determining adverse reactions, and predicting the direction of disease development.
[Biomedicine & Pharmacotherapy]

Sorry, but the selected Zotpress account can't be found.

AbstractGraphical Abstract
Exit mobile version